Background Biliary tract cancers, which arise from the intrahepatic or extrahepatic bile ducts
and the gallbladder, generally have a poor prognosis and are rising in incidence worldwide …

Background We evaluated candidate circulating serum cytokines, chemokines and growth
factors in patients with locally/regionally advanced melanoma receiving neoadjuvant …

Background Surgery alone is often inadequate for advanced-stage gastric cancer. Surgical
complications may delay adjuvant therapy. Understanding these complications is needed for …

Purpose: Despite aggressive chemotherapy, radiotherapy, surgery, or combination
approaches, the survival rate of patients with esophageal cancer remains poor. Recent …

This laboratory recently identified a human gene that encodes a novel folate transporter
[Homo sapiens proton-coupled folate transporter (Hs PCFT); SLC46A1] required for …

Association of Activated Transcription Factor Nuclear Factor κB With Chemoradiation
Resistance and Poor Outcome in Esophageal C Page 1 Association of Activated …

Rectal cancer predominantly affects patients older than 70 years, with peak incidence at age
80 to 85 years. However, the standard treatment paradigm for rectal cancer oftentimes …

Colorectal cancer incidence and death rates have been declining over the past 10 years.
However, it remains the second leading cause of death in men ages 60–79 and the third …

Background Small cell cancer (SCC) of the esophagus is an uncommon malignancy with
perceived poor prognosis, but there are few data to guide therapeutic decisions. We …

Objectives: Vascular endothelial growth factor overexpression, seen in 42% to 76% of biliary
tract cancers (BTCs), correlates with poor survival. We explored the safety/efficacy and …